HIGHLIGHTS
- who: Caiping Gao and Chong He from the University of New Mexico have published the research work: A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis, in the Journal: (JOURNAL)
- what: The authors evaluated the application value of NAR as a diagnostic biomarker in patients with UC and The authors employed a newly-identified index calculated as the ratio of neutrophil percentages (from complete blood cell tests) over serum albumin levels (from serum biochemical tests).
- how: Participants This prospective study was conducted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.